Clostridium difficile toxins: more than mere inhibitors of Rho proteins H Genth, SC Dreger, J Huelsenbeck, I Just The international journal of biochemistry & cell biology 40 (4), 592-597, 2008 | 146 | 2008 |
C3 peptide enhances recovery from spinal cord injury by improved regenerative growth of descending fiber tracts F Boato, S Hendrix, SC Huelsenbeck, F Hofmann, G Große, S Djalali, ... Journal of cell science 123 (10), 1652-1662, 2010 | 131 | 2010 |
The lipid lowering drug lovastatin protects against doxorubicin-induced hepatotoxicity C Henninger, J Huelsenbeck, S Huelsenbeck, S Grösch, A Schad, ... Toxicology and applied pharmacology 261 (1), 66-73, 2012 | 96 | 2012 |
Rac1 protein signaling is required for DNA damage response stimulated by topoisomerase II poisons SC Huelsenbeck, A Schorr, WP Roos, J Huelsenbeck, C Henninger, ... Journal of Biological Chemistry 287 (46), 38590-38599, 2012 | 91 | 2012 |
Chronic heart damage following doxorubicin treatment is alleviated by lovastatin C Henninger, S Huelsenbeck, P Wenzel, M Brand, J Huelsenbeck, ... Pharmacological research 91, 47-56, 2015 | 83 | 2015 |
Difference in the Cytotoxic Effects of Toxin B from Clostridium difficile Strain VPI 10463 and Toxin B from Variant Clostridium difficile Strain 1470 J Huelsenbeck, S Dreger, R Gerhard, H Barth, I Just, H Genth Infection and immunity 75 (2), 801-809, 2007 | 82 | 2007 |
Upregulation of the Immediate Early Gene Product RhoB by Exoenzyme C3 from Clostridium limosum and Toxin B from Clostridium difficile J Huelsenbeck, SC Dreger, R Gerhard, G Fritz, I Just, H Genth Biochemistry 46 (16), 4923-4931, 2007 | 59 | 2007 |
A 29‐amino acid fragment of Clostridium botulinum C3 protein enhances neuronal outgrowth, connectivity, and reinnervation M Höltje, S Djalali, F Hofmann, A Münster-Wandowski, S Hendrix, F Boato, ... The FASEB Journal 23 (4), 1115-1126, 2009 | 58 | 2009 |
C3 peptide promotes axonal regeneration and functional motor recovery after peripheral nerve injury SC Huelsenbeck, A Rohrbeck, A Handreck, G Hellmich, E Kiaei, ... Neurotherapeutics 9 (1), 185-198, 2012 | 42 | 2012 |
Inhibition of cytokinesis by Clostridium difficile toxin B and cytotoxic necrotizing factors—reinforcing the critical role of RhoA in cytokinesis SC Huelsenbeck, M May, G Schmidt, H Genth Cell motility and the cytoskeleton 66 (11), 967-975, 2009 | 33 | 2009 |
Killing of Rat Basophilic Leukemia Cells by Lethal Toxin from Clostridium sordellii: Critical Role of Phosphatidylinositide 3′-OH Kinase/Akt Signaling SC Dreger, F Schulz, J Huelsenbeck, R Gerhard, F Hofmann, I Just, ... Biochemistry 48 (8), 1785-1792, 2009 | 27 | 2009 |
Distinct kinetics of (H/K/N) Ras glucosylation and Rac1 glucosylation catalysed by Clostridium sordellii lethal toxin SC Huelsenbeck, I Klose, M Reichenbach, J Huelsenbeck, H Genth FEBS letters 583 (19), 3133-3139, 2009 | 24 | 2009 |
Therapeutic effects of Clostridium botulinum C3 exoenzyme I Just, A Rohrbeck, SC Huelsenbeck, M Hoeltje Naunyn-Schmiedeberg's archives of pharmacology 383, 247-252, 2011 | 22 | 2011 |
Clostridium botulinum C3 exoenzyme: Rho-inactivating tool in cell biology and a neurotrophic agent I Just, SC Huelsenbeck, H Genth The Open Toxinology Journal 3 (1), 2010 | 12 | 2010 |
Expression and cytoprotective activity of the small GTPase RhoB induced by the Escherichia coli cytotoxic necrotizing factor 1 SC Huelsenbeck, D Roggenkamp, M May, J Huelsenbeck, C Brakebusch, ... The International Journal of Biochemistry & Cell Biology 45 (8), 1767-1775, 2013 | 5 | 2013 |
Rho-inhibiting toxins I Just, SC Dreger, H Genth Toxicology Letters 189, S18-S19, 2009 | 1 | 2009 |
Mentoring in der Hochschulmedizin S Hülsenbeck Praxishandbuch Mentoring in der Wissenschaft, 355-366, 2017 | | 2017 |
Polypeptides and use thereof for treatment of traumatic or degenerative neuronal injury G Ahnert-Hilger, G Groβe, F Hofmann, I Just, M Höltje, S Hülsenbeck US Patent 8,747,841, 2014 | | 2014 |
Cytoprotective activity of the small GTPase RhoB expressed upon treatment of fibroblasts with the E. coli cytotoxic necrotizing factor 1 H Genth, S Huelsenbeck, M May, D Roggenkamp, I Just, G Fritz, K Rottner, ... NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY 386, S27-S27, 2013 | | 2013 |
205 Evidence for Geno-and Cytoprotective Properties of Lipid Lowering Drugs (statins) in a BALB/c Mouse Model C Henninger, J Huelsenbeck, SC Huelsenbeck, G Fritz european journal of cancer, S50, 2012 | | 2012 |